The Pivotal Roles Genomics and Flow Cytometry Play in Immuno-oncology Clinical Development
Clinical Trials Laboratories in the Immuno-oncology Setting
Learn how clinical trial laboratories use new innovations in flow cytometry and genomics to advance your immuno-oncology (I-O) studies.
You’ll hear from our Chief Pathologist and Senior Medical Director, Radha Krishnan, M.D., as she also explains:
- 3 new challenges contributing to the complexity of I-O therapy development and how new approaches in flow cytometry and genomics are evolving to inform clinical decision making.
- 6 common I-O assessments, such as gene expression profiling, and their genomic applications.
- How we used global, harmonized systems and stringent quality control measures to create best practices and help a sponsor move from a Phase I to a Phase III study.
Contact us to learn how we can advance your immuno-oncology drug development program. Download